PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401449
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401449
Global Transcatheter Pulmonary Valve Market is valued approximately USD 43.99 Million in 2022 and is anticipated to grow with a healthy growth rate of more than 6.0% over the forecast period 2023-2030. A Transcatheter Pulmonary Valve is a medical device used in the field of interventional cardiology to treat certain heart conditions. This innovative valve is designed to be implanted without the need for open-heart surgery. It is typically used to replace a dysfunctional or damaged pulmonary valve in patients, most commonly those who have previously undergone surgical repair of congenital heart defects. The Transcatheter Pulmonary Valve Market is expanding because of factors such as increasing prevalence of various cardiovascular diseases, increasing incidences of congenital heart diseases (CHD) and rising demand for minimally invasive procedures.
As the prevalence of cardiac vascular diseases, including congenital heart defects, continues to rise due to factors such as an aging population, lifestyle choices, and improved diagnostic methods, the demand for innovative treatments such as Transcatheter Pulmonary Valves is expected to increase. Patients are increasingly seeking less invasive, safer, and more effective treatment options, which has spurred the growth of the market. For instance, the Centres for Disease Control and Prevention (CDC) 2022 report states that in 2020, 20.1 million persons aged 20 and older had coronary artery disease. Furthermore, the same report stated that every year about 805,000 Americans have a heart attack. Thus, rising chronic cardiac diseases are driving the market growth. Moreover, the National Library of Medicine announced in September 2022 that more than 200,000 heart valve replacement procedures are carried out annually worldwide, with an increase to 8,50,000 per year expected by 2050. These rising heart valve replacement procedures indicate the rising prevalence of cardiac vascular diseases which is further driving the market growth. In addition, rising technological advancement and favorable regulatory support are creating new opportunities for market growth. However, the availability of alternative technologies stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Transcatheter Pulmonary Valve Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to factors such as the robust healthcare sector, coupled with a rising incidence of conditions such as pulmonary stenosis and regurgitation. Furthermore, the market is expected to expand owing to increased awareness, a growing appetite for cutting-edge heart valve solutions, and a rise in healthcare spending in the region. Whereas, Asia Pacific is projected to register the fastest growth owing to factors such as rising healthcare spending, rising prevalence of cardiac disorders, rising number of heart replacement surgery, favorable government policies for product development in the region,
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable